Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial - Concepedia

Concepedia

Publication | Open Access

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial

DOI Full Paper Access

389

Citations

16

References

2019

Year

N.W. Clarke, Amin Ali, Fiona C. Ingleby, Alex Hoyle, Claire Amos, Gerhardt Attard, Chris Brawley, J. Calvert, S. Chowdhury, Audrey Cook,

Annals of Oncology

References

	Year	Citations

Page 1